Variability in measures of coronary lumen dimensions using quantitative coronary angiography
DM Herrington,
M Siebes,
DK Sokol,
CO Siu,
and
GD Walford
Division of Cardiology, Bowman Gray School of Medicine, Winston-Salem, North Carolina 27157-1045.
OBJECTIVES. The purpose of this study was to determine the true total variability of quantitative coronary angiographic measures and their components in the clinical setting. BACKGROUND. Many studies describe quantitative coronary angiographic variability on the basis of repeated quantitative coronary angiographic measures from the same cineangiogram. Although these studies characterize well the performance of quantitative coronary angiographic analysis methods, they do not include other potentially important sources of variability in results of this procedure, such as day to day variations in patients and equipment or variability in selection of frames for analysis. METHODS. Coronary angiograms from 20 patients who underwent diagnostic angiography followed by percutaneous transluminal coronary angioplasty an average of 2.9 days later were reviewed. A total of 30 lesions well visualized in both films were analyzed multiple times using an automated first-derivative edge-detection quantitative coronary angiographic technique. RESULTS. The coefficient of variation for quantitative coronary angiographic measures of the same lesions from separate angiograms ranged from 8.11% to 14.01%. Average diameter was the least variable and percent diameter stenosis the most variable. Day to day variations in the patient, procedure and equipment accounted for an average of 30% of the total variability. Of the remaining variability, only 13.26% was due to variability in frame selection. CONCLUSIONS. These results provide useful information for planning clinical studies using quantitative coronary angiography, identify areas where additional improvements in this technology are needed and define more clearly the applicability of quantitative coronary angiography in the setting of routine clinical practice.
This article has been cited by other articles:

|
 |

|
 |
 
A. Arbab-Zadeh, J. Texter, K. M. Ostbye, K. Kitagawa, J. Brinker, R. T. George, J. M. Miller, J. C. Trost, R. A. Lange, J. A. C. Lima, et al.
Quantification of lumen stenoses with known dimensions by conventional angiography and computed tomography: implications of using conventional angiography as gold standard
Heart,
September 1, 2010;
96(17):
1358 - 1363.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. Albiero, S. Silber, C. Di Mario, C. Cernigliaro, S. Battaglia, B. Reimers, A. Frasheri, V. Klauss, J. M. Auge, P. Rubartelli, et al.
Cutting balloon versus conventional balloon angioplasty for the treatment of in-stent restenosis: Results of the restenosis cutting balloon evaluation trial (RESCUT)
J. Am. Coll. Cardiol.,
March 17, 2004;
43(6):
943 - 949.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. O. Costantini, A. J. Lansky, G. S. Mintz, K. Shirai, G. Dangas, R. Mehran, M. Fahy, S. Slack, M. Coral, P. S. Teirstein, et al.
Intravascular brachytherapy for native coronary ostial in-stent restenotic lesions
J. Am. Coll. Cardiol.,
May 21, 2003;
41(10):
1725 - 1731.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. vom Dahl, U. Dietz, P. K. Haager, S. Silber, L. Niccoli, H. J. Buettner, F. Schiele, M. Thomas, P. Commeau, D. R. Ramsdale, et al.
Rotational Atherectomy Does Not Reduce Recurrent In-Stent Restenosis: Results of the Angioplasty Versus Rotational Atherectomy for Treatment of Diffuse In-Stent Restenosis Trial (ARTIST)
Circulation,
February 5, 2002;
105(5):
583 - 588.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
P. J. Scanlon, D. P. Faxon, A.-M. Audet, B. Carabello, G. J. Dehmer, K. A. Eagle, R. D. Legako, D. F. Leon, J. A. Murray, S. E. Nissen, et al.
ACC/AHA guidelines for coronary angiography: A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on Coronary Angiography) developed in collaboration with the Society for Cardiac Angiography and Interventions
J. Am. Coll. Cardiol.,
May 1, 1999;
33(6):
1756 - 1824.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
F.-C. Schoebel, F. Gradaus, K. Ivens, P. Heering, T. W. Jax, B. Grabensee, B.-E. Strauer, and M. Leschke
Restenosis after elective coronary balloon angioplasty in patients with end stage renal disease: a case-control study using quantitative coronary angiography
Heart,
October 1, 1997;
78(4):
337 - 342.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
G. Montalescot, A. Ankri, E. Vicaut, G. Drobinski, Y. Grosgogeat, and D. Thomas
Fibrinogen After Coronary Angioplasty as a Risk Factor for Restenosis
Circulation,
July 1, 1995;
92(1):
31 - 38.
[Abstract]
[Full Text]
|
 |
|

|
 |

|
 |
 
D. Keane, J. Haase, C. J. Slager, E. M. van Swijndregt, K. G. Lehmann, Y. Ozaki, C. di Mario, R. Kirkeeide, and P. W. Serruys
Comparative Validation of Quantitative Coronary Angiography Systems : Results and Implications From a Multicenter Study Using a Standardized Approach
Circulation,
April 15, 1995;
91(8):
2174 - 2183.
[Abstract]
[Full Text]
|
 |
|
|